Development of 68Ga ethyl cysteinate dimer for PET studies

Journal of Radioanalytical and Nuclear Chemistry

Volumn 307, Issue 1, 2016, Pages 725-732

  Mirzaei, Alireza ^a   Jalilian, Amir R ^a   Shabani, Gholamali ^a   Fakhari, Ashraf ^b   Akhlaghi, Mehdi ^c   Beiki, Davood ^c  

^a NUCLEAR SCIENCE AND TECHNOLOGY RESEARCH INSTITUTE   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

68Ga; Biodistribution; Cerebral blood flow agent; Ethyl cysteinate dimer; PET CT

Indexed keywords

CYSTEINE ETHYL ESTER; DRUG METABOLITE; GALLIUM; GALLIUM 68; GALLIUM ETHYL CYSTEINATE G 68; IRON; TECHNETIUM 99M; TIN; UNCLASSIFIED DRUG; ZINC;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; BRAIN BLOOD FLOW; COMPLEX FORMATION; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; DRUG DETERMINATION; DRUG DISTRIBUTION; DRUG PURITY; DRUG STABILITY; DRUG STRUCTURE; DRUG SYNTHESIS; DRUG TISSUE LEVEL; ELUTION; HUMAN; IN VITRO STUDY; ISOTOPE LABELING; NONHUMAN; PARTITION COEFFICIENT; QUALITY CONTROL; RADIOACTIVITY; RADIOCHEMISTRY; RADIOISOTOPE SYNTHESIS; RAT; URINARY EXCRETION;

EID: 84953361406     PISSN: 02365731     EISSN: 15882780     Source Type: Journal    
DOI: 10.1007/s10967-015-4185-3     Document Type: Article

References (24)

1. 99mTc-ethyl cysteinate dimer in non human primates. Stroke 21:1059–1063
2. Vallabhajosula S, Zimmerman RE, Picard M, Stritzke P, Mena I, Hellman RS, Tikofsky RS, Stabin MG, Morgan RA, Goldsmith SJ (1989) Technetium-99m ECD: a new brain imaging agent: in vivo kinetics and biodistribution studies in normal human subjects. J Nucl Med 30:599–604
3. Holman BL, Hellman RS, Goldsmith SJ, Mena IG, Leveille J, Gherardi PG, Moretti JL, Bischof-Delaloye A, Hill TC, Rigo PM (1989) Biodistribution, dosimetry and clinical evaluation of technetium-99m-ethyl cysteinate dimer in normal subjects and in patients with chronic cerebral infarction. J Nucl Med 30:1018–1023
4. Kimura N, Nakama H, Nakamura K, Aso Y, Kumamoto T (2012) Effect of white matter lesions on brain perfusion in Alzheimer’s disease. Dement Geriatr Cogn Disord 34:256–261
5. Krishnananthan R, Minoshima S, Lewis D (2007) Tc-99m ECD neuro-SPECT and diffusion weighted MRI in the detection of the anatomical extent of subacute stroke: a cautionary note regarding reperfusion hyperemia. Clin Nucl Med 32:700–702
6. 99mTc-ECD single-photon emission computed tomography in patients diagnosed with major depressive disorder. J Affect Disord 140:296–299
7. 68Ga-ECC as a PET renal imaging agent. DOI, Nucl Med Mol Imaging. doi:10.1007/s13139-015-0323-7
8. Firestone RB, Shirley VS, Baglin CM, Chu SYF, Zipkin J (1996, 1998, 1999) Table of isotopes, 8th edn. Wiley, New York; with CD-ROM
9. DDEP Decay data evaluation project data (2008). http://www.nucleide.org/DDEP_WG/DDEPdata.htm
10. Saha GB, MacIntyre WJ, Go RT (1994) Radiopharmaceuticals for brain imaging. Semin Nucl Med 24:324–349
11. Blondeau P, Berse C, Gracel D (1967) Dimerization of an intermediate during the sodium in liquid ammonia reduction of L-thiazolidine-4-carboxylic acid. Can J Chem 45:49–52
12. 68Ga generator’ based on the nanoceria-polyacrylonitrile composite Sorbent. Cancer Biother Radiopharm 28:631–637
13. 66Ga]bleomycin complex as a possible PET radiopharmaceutical. J Radioanal Nucl Chem 264:617
14. 99mTc-PnAO); a potential brain radiopharmaceutical. Eur J Nucl Med 9:511–516
15. Walovitch RC, Williams SJ, Morgan RA, Garrity ST, Cheesman EH (1988) Pharmacological characterization of Tc-99m ECD in non-human primates as a new agent for brain perfusion imaging. J Nucl Med 29:788
16. Walovitch RC, Franceschi M, Picard M et al (1991) Metabolism of 99mTc-L, L-ethyl cysteinate dimer in healthy volunteers. Neuropharmacology 30:283–292
17. Inoue Y, Momose T, Ohtake T et al (1997) Metabolism of technetium-99m-L,L-ethyl cysteinate dimer in rat and cynomolgus monkey tissue. J Nucl Med 38:1731–1737
18. http://www.parsisotope.com/pages/?action=download&dl=20140922103143
19. Francesconi LC, Liu BL, Billings JJ, Carroll PJ, Graczyk G, Kung HF (1991) Synthesis, characterization and solid state structure of a neutral gallium(III) amino thiolate complex: a potential radiopharmaceutical for PET imaging. J Chem Soc Chem Commun 2:94–95
20. Zheng YY, Saluja S, Yap GP, Blumenstein M, Rheingold AL, Francesconi LC (1996) Gallium and indium complexes of bis(amino thiol) (N(2)S(2)) ligands. Inorg Chem 35:6656–6666
21. Kung HF, Liu BL, Mankoff D, Kung MP, Billings JJ, Francesconi LC et al (1990) A new myocardial imaging agent: synthesis, characterization, and biodistribution of gallium-68-BAT-TECH. J Nucl Med 31:1635–1640
22. Cutler CS, Giron MC, Reichert DE, Snyder AZ, Herrero P, Anderson CJ et al (1999) Evaluation of gallium-68 tris(2-mercaptobenzyl)amine: a complex with brain and myocardial uptake. Nucl Med Biol 26:305–316
23. Plössl K, Chandra R, Qu W, Lieberman BP, Kung M-P, Zhou R, Huang B, Kung HF (2008) A novel gallium bisaminothiolate complex as a myocardial perfusion imaging agent. Nucl Med Biol 35:83–90
24. 67Ga]-thiosemicarbazone complex as tumor imaging agent. Sci Pharm 77:343–354